Clavulanic acid is a compound that disables the defenses bacteria use to resist antibiotics. It has almost no bacteria-killing power on its own, but when paired with an antibiotic like amoxicillin, it restores the antibiotic’s ability to work against resistant bacteria. You’ll find it in common prescriptions sold under brand names like Augmentin, where it’s listed as “clavulanate potassium,” the shelf-stable salt form of the same molecule.
Why Antibiotics Sometimes Need Help
Many bacteria protect themselves by producing enzymes called beta-lactamases. These enzymes break apart the core structure of penicillin-type antibiotics before they can do their job. This is one of the most common ways bacteria become resistant to drugs like amoxicillin, ampicillin, and similar antibiotics. Without something to neutralize those enzymes, the antibiotic gets destroyed before it ever reaches its target.
Clavulanic acid solves this problem. It’s shaped enough like a penicillin that the bacterial enzyme grabs onto it instead. Once it latches on, clavulanic acid permanently disables the enzyme through a two-step chemical reaction: it first bonds to a key part of the enzyme’s active site, then restructures itself and attacks a second spot, locking the enzyme in a permanently inactive state. Scientists call this “suicide inhibition” because clavulanic acid sacrifices itself in the process. A single enzyme molecule may chew through about 115 molecules of clavulanic acid before it’s finally shut down for good, but once it is, it can no longer protect the bacterium.
What It’s Combined With and Why
In medications, clavulanic acid is almost always paired with amoxicillin. The combination comes in several standard ratios depending on the formulation. Regular tablets typically contain either 500 mg of amoxicillin with 125 mg of clavulanate, or 875 mg of amoxicillin with 125 mg of clavulanate. Extended-release versions use 1,000 mg of amoxicillin with just 62.5 mg of clavulanate. The clavulanate dose stays relatively low across all formulations because you only need enough to knock out the bacterial enzymes, not kill bacteria directly.
The combination is on the World Health Organization’s List of Essential Medicines, where it’s classified as a core “access group” antibiotic, meaning it should be widely available as a first-line treatment option.
Infections It’s Used For
Adding clavulanic acid to amoxicillin broadens the range of bacteria the antibiotic can handle. The combination is effective against several species that would otherwise shrug off amoxicillin alone, including Staph aureus, E. coli, Klebsiella (which always produces beta-lactamase), Haemophilus influenzae, and Moraxella catarrhalis.
In practice, this means doctors reach for amoxicillin-clavulanate for infections where resistant bacteria are likely culprits:
- Sinus infections caused by resistant strains of H. influenzae or M. catarrhalis
- Ear infections (otitis media) from the same organisms
- Lower respiratory tract infections including some forms of bronchitis and pneumonia
- Skin infections caused by resistant Staph aureus, E. coli, or Klebsiella
- Urinary tract infections caused by resistant E. coli, Klebsiella, or Enterobacter
Where It Comes From
Clavulanic acid was identified in 1976 from a soil bacterium called Streptomyces clavuligerus. Researchers found it in the fermentation broth of the organism, where it naturally functions as a chemical weapon against competing bacteria that produce beta-lactamases. It belongs to a class of compounds called clavams, which share a core structure with penicillins but evolved for enzyme inhibition rather than direct bacterial killing.
Side Effects
The most common complaint with amoxicillin-clavulanate is digestive upset, particularly diarrhea. Interestingly, lab research in animal tissue suggests clavulanic acid itself doesn’t directly increase gut contractions. Instead, it’s the amoxicillin component that stimulates intestinal muscle activity through nerve-mediated mechanisms. However, the clavulanate component does contribute to gut disruption in a different way: by altering the balance of intestinal bacteria, which can trigger loose stools. Diarrhea is more frequent with amoxicillin-clavulanate than with amoxicillin alone, and taking it with food can help reduce stomach discomfort.
A rarer but more serious concern is liver injury. Amoxicillin-clavulanate accounts for roughly 17% of all drug-induced liver injury hospitalizations, and the clavulanate component appears to be the primary driver. The overall rate is low, around 0.014% of people who take the drug, but susceptibility is partly genetic. Specific immune system gene variants influence who is at risk. Liver problems typically show up days to weeks after starting the medication and can include jaundice, dark urine, or upper abdominal pain.
How Bacteria Fight Back
Clavulanic acid is effective against the most common class of beta-lactamase enzymes (class A), but it doesn’t work against all types. Class C beta-lactamases, produced by some hospital-acquired bacteria, are not inhibited by clavulanic acid.
Even among bacteria with class A enzymes, resistance to clavulanic acid is emerging. Single amino acid changes in the enzyme’s structure can dramatically reduce clavulanic acid’s ability to bind. For example, one well-studied mutation increases the amount of clavulanic acid needed to inhibit the enzyme by more than 300-fold. These mutations have been found in clinical isolates, meaning they’re not just a laboratory curiosity. Some of these structural changes are subtle, involving tiny shifts in the enzyme’s three-dimensional shape that make clavulanic acid less able to latch on and complete its suicide inhibition process. This is one reason why newer beta-lactamase inhibitors have been developed for more resistant infections, though amoxicillin-clavulanate remains one of the most widely prescribed antibiotic combinations worldwide.